All In Biotech

Drug Trial Radar · NCT00300755

Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)

A Multicenter, Randomized, Double-Blind Study of the Clinical Outcomes, Safety and Tolerability of Multiple Doses of Pantoprazole Sodium Enteric-Coated Spheroids in Children Ages 1 to 5 With Endoscopically Proven Symptomatic Gastroesophageal Reflux Disease (GERD)

Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

60

Actual

Start

May 2006

Primary completion

Apr 2008

Study completion Apr 2008

Sponsor

Sponsor type
Industry
Collaborators
Nycomed
First posted
Mar 9, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 1 year, up to 5 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the clinical outcomes of treatment with oral pantoprazole in children 1 through 5 years of age with endoscopically proven symptomatic GERD.

Conditions

  • Gastroesophageal Reflux

Interventions

  • pantoprazole sodium enteric-coated spheroidDrug

    Pediatric spheroids administered once daily for 8 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Weekly Gastroesophageal Reflux Disease (GERD) Symptom Scores (WGSS)Time frame: Baseline and Weeks 1, 2, 3, 4, 5, 6, 7, 8, and Final Week

Locations

43 sites in 2 countries. Site status is shown where the registry gives one.

  • Site not named

    Mobile, Alabama

  • Site not named

    Phoenix, Arizona

  • Site not named

    Oakland, California

  • Site not named

    Orange, California

  • Site not named

    Sacramento, California

  • Site not named

    San Diego, California

  • Site not named

    Wilmington, Delaware

  • Site not named

    Washington D.C., District of Columbia

  • Site not named

    Gainesville, Florida

  • Site not named

    Jacksonville, Florida

  • Site not named

    Miami, Florida

  • Site not named

    Orlando, Florida

  • Site not named

    Pensacola, Florida

  • Site not named

    Peoria, Illinois

  • Site not named

    Lexington, Kentucky

  • Site not named

    Louisville, Kentucky

  • Site not named

    Boston, Massachusetts

  • Site not named

    Boston, Massachusetts

  • Site not named

    Flint, Michigan

  • Site not named

    Southfield, Michigan

  • Site not named

    Jackson, Mississippi

  • Site not named

    Omaha, Nebraska

  • Site not named

    Las Vegas, Nevada

  • Site not named

    Egg Harbor, New Jersey

  • Site not named

    Morristown, New Jersey

  • Site not named

    Buffalo, New York

  • Site not named

    New York, New York

  • Site not named

    Oklahoma City, Oklahoma

  • Site not named

    Danville, Pennsylvania

  • Site not named

    Philadelphia, Pennsylvania

  • Site not named

    Houston, Texas

  • Site not named

    Temple, Texas

  • Site not named

    Norfolk, Virginia

  • Site not named

    Charleston, West Virginia

  • Site not named

    Huntington, West Virginia

  • Site not named

    Milwaukee, Wisconsin

  • Site not named

    Edmonton, Alberta, Canada

  • Site not named

    St. John's, Newfoundland and Labrador, Canada

  • Site not named

    Hamilton, Ontario, Canada

  • Site not named

    London, Ontario, Canada

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.